Bausch Health Companies Inc BHC

Primary Symbol: T.BHC

Healthcare

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.

TSX:BHC - Post by User

Bausch Health Companies Inc > Delaware

<< Previous

Bullboard Posts

Next >>

Comment by savyinvestor333on Jul 28, 2022 1:01pm

287 Views

Post# 34857469

RE:Delaware

Bought 4000 just before the halt. The BLCO shares in the US have come back alot since the halt. Crossing my fingers this opens substancially higher after the news release. GLTA P.S Just bought for a quick flip but will see where this goes.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing